6533b821fe1ef96bd127b06a
RESEARCH PRODUCT
Aulogous fibrin sealant (Vivostat(®)) in the neurosurgical practice: Part II: Vertebro-spinal procedures.
Rosario MaugeriLuigi BasileDomenico Gerardo IacopinoFrancesca GrazianoFavia Mecciosubject
medicine.medical_specialtycerebrospinal fluid fistulaFibrin03 medical and health sciences0302 clinical medicineBleeding controlCerebrospinal fluid fistulamedicineFibrin gluebiologybusiness.industrySettore MED/27 - NeurochirurgiaSealantSurgical Neurology International: SpineSurgerydural sealant030220 oncology & carcinogenesisHemostasisDural sealantbiology.proteinAutologous fibrin gluehemostasisSurgeryNeurology (clinical)dural repairhemorrhagebusiness030217 neurology & neurosurgerydescription
Background Epidural hematomas, cerebrospinal fluid fistula, and spinal infections are challenging postoperative complications following vertebro-spinal procedures. We report our preliminary results using autologous fibrin sealant as both fibrin glue and a hemostatic during these operations. Methods Prospectively, between January 2013 and March 2015, 68 patients received an autologous fibrin sealant prepared with the Vivostat(®) system applied epidurally to provide hemostasis and to seal the dura. The surgical technique, time to bleeding control, and associated complications were recorded. Results Spinal procedures were performed in 68 patients utilizing autologous fibrin glue/Vivostat(®) to provide rapid hemostasis and/or to seal the dura. Only 2 patients developed postoperative dural fistulas while none exhibited hemorrhages, allergic reactions, systemic complications, or infections. Conclusions In this preliminary study, the application of autologous fibrin sealant with Vivostat(®) resulted in rapid hemostasis and/or acted as an effective dural sealant. Although this product appears to be safe and effective, further investigations are warranted.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-07-25 | Surgical neurology international |